Form D · Venture Capital Fund
Biospring Partners CHR, LP
New York, NY · CIK 0002126989
Offering snapshot reported Apr 8, 2026 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2026 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-579547
Source: Form D, filed Apr 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A N/A Biospring Management Llc | Promoter |
| N/A N/A Biospring Partners Fund Gp, Llc | Promoter |
| Jeff Bullock | Promoter |
| Michelle Detwiler | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
40 W. 57 Th Street, Suite 1815
New York, NY, 10019
New York, NY, 10019